Heparan sulfate: Growth control with a restricted sequence menu

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 357-361

  Gallagher, J T ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; PROTEOHEPARAN SULFATE;

AMINO ACID SEQUENCE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034907578     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13713     Document Type: Review

References (56)

1. Proteoglycans: Structures and interactions
2. Specificities of heparan sulphate proteoglycans in developmental processes
3. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion
4. Signalling through the syndecan proteoglycans
5. Matrix proteoglycans: From molecular design to cellular function
6. Molecular structure of heparan sulfate and interactions with growth factors and morphogens
7. Heparan sulfate proteoglycans: Intricate molecules with intriguing functions
8. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan
9. Molecular diversity of heparan sulfate
10. Distribution of iduronate-2-sulphate in heparan sulphate. Evidence for an ordered polymeric structure
11. Liver heparan sulfate structure. A novel molecular design
12. Domain structure of heparan sulfates from bovine organs
13. Highly sensitive sequencing of the sulfated domains of heparan sulfate
14. Structural diversity of N-sulphated heparan sulphate domains
15. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues
16. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody
17. N.m.r. and molecular-modelling studies of the solution conformation of heparin
18. Conformation and dynamics of heparin and heparan sulfate
19. Heparin structure and interactions with basic fibroblast growth factor
20. Heparin and heparan sulfate: Biosynthesis, structure and function
21. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
22. Molecular organization of the interferon γ-binding domain in heparan sulphate
23. The interaction of transforming growth factor-β with heparin/heparan sulfate is isoform-specific
24. Defining the Interleukin-8-binding domain of heparan sulfate
25. Specific binding of the chemokine platelet factor 4 to heparan sulfate
26. The heparan sulfate binding sequence of interferon-γ increased the on rate of the interferon-γ-interferon-γ receptor complex formation
27. Glycosaminoglycan-protein interactions: A question of specificity
28. The anticoagulant activation of antithrombin by heparin
29. The interaction and regulation of basic and acidic fibroblast growth factors by heparan sulfate
30. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity
31. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: Differential requirements for the modulation of FGF-1 and FGF-2
32. Structural modification of fibroblast growth factor binding heparan sulfate at a determinative stage of neural development
33. Fibroblast growth factor receptor signalling is dictated by specific heparan sulfate saccharides
34. Sequence analysis of heparan sulphate epitopes with graded affinities for FGF1 and FGF2
35. Receptors for fibroblast growth factors
36. The elusive functions of proteoglycans: In vivo veritas
37. The cell-surface proteoglycan dally regulates wingless signalling in Drosophila
38. Tout-velu is a Drosophila homologue of the putative tumour suppressor Ext-1 and is needed for Hh diffusion
39. Heparan sulfate: Lessons from knockout mice
40. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase
41. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice
42. Proteoglycans: Master regulators of molecular encounter?
43. Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors?
44. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor
45. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate
46. MAPK phosphorylation and IkB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts
47. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor
48. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans
49. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding
50. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor is required for mitogenesis
51. Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation
52. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
53. Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulfate and heparin are separate families of N-sulphated polysaccharides
54. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney
55. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry
56. Automated solid-phase synthesis of oligosaccharides